Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties.

IF 3.3 3区 医学 Q1 UROLOGY & NEPHROLOGY Journal of Sexual Medicine Pub Date : 2025-04-15 DOI:10.1093/jsxmed/qdaf018
Hammoda Abu-Odah, Ka-Yan Ho, Chi-Fai Ng, Siyuan Wu, Katherine-Ka-Wai Lam, Janelle Yorke
{"title":"Patient-reported outcome measures (PROMs) used to assess sexual functioning in prostate cancer patients: a systematic review of psychometric properties.","authors":"Hammoda Abu-Odah, Ka-Yan Ho, Chi-Fai Ng, Siyuan Wu, Katherine-Ka-Wai Lam, Janelle Yorke","doi":"10.1093/jsxmed/qdaf018","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer (PCa) significantly impacts patients' sexual functioning and quality of life. Patient-reported outcome measures (PROMs) are essential for accurately assessing these issues, yet a comprehensive evaluation of their psychometric properties in PCa patients is lacking.</p><p><strong>Aims: </strong>This systematic review aimed to provide a comprehensive evaluation of all generic and specific PROMs used to assess sexual functioning in PCa patients and make recommendations the application of PROMs in this patient group.</p><p><strong>Methods: </strong>Six electronic databases were searched from up to May 5, 2024. Studies reporting the development and/or validation of PROMs for PCa patients or generic instruments administered to this population were included. The COSMIN risk of bias checklist was adopted to assess the methodological quality and psychometric properties of included PROMs. Psychometric properties of the PROM in each included study were rated against the criteria for good measurement properties based on the COSMIN guideline.</p><p><strong>Outcomes: </strong>The main outcome was to identify the appropriate PROM that can be adopted and used for assessing sexual functioning in PCa patients in clinical setting.</p><p><strong>Results: </strong>A total of 10 PROMs were identified across 32 studies, primarily focusing on localized PCa patients after radical prostatectomy. The Expanded Prostate Cancer Index Composite (EPIC-26) was the most frequently evaluated and widely used PROM in clinical practice. EPIC-26 (Spanish, Italian, Chinese versions) and UCLA Prostate Cancer Index (UCLA-PCI) demonstrated better psychometric properties compared to other scales. However, no PROM met all COSMIN standards.</p><p><strong>Clinical implications: </strong>In a clinical setting, it is crucial to utilize well-validated PROMs with good psychometric properties to effectively identify patients with PCa experiencing sexual difficulties who may require additional support.</p><p><strong>Strengths and limitations: </strong>We applied strict inclusion criteria related to study design and study population, ensuring the assumption of transitivity and the consistency of the analysis.</p><p><strong>Conclusion: </strong>Although EPIC-26 is a shortened version with strong psychometric properties, it may still be too lengthy for patients with significant health issues. Furthermore, the included PROMs do not address issues related to partner relationships, or the psychological impact of sexual dysfunction in sufficient detail. Future research should aim to develop and validate new PROMs that fill these gaps. These tools should be both psychometrically robust and practical for routine use, enabling real-time monitoring and improved care delivery.</p>","PeriodicalId":51100,"journal":{"name":"Journal of Sexual Medicine","volume":" ","pages":"605-624"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jsxmed/qdaf018","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prostate cancer (PCa) significantly impacts patients' sexual functioning and quality of life. Patient-reported outcome measures (PROMs) are essential for accurately assessing these issues, yet a comprehensive evaluation of their psychometric properties in PCa patients is lacking.

Aims: This systematic review aimed to provide a comprehensive evaluation of all generic and specific PROMs used to assess sexual functioning in PCa patients and make recommendations the application of PROMs in this patient group.

Methods: Six electronic databases were searched from up to May 5, 2024. Studies reporting the development and/or validation of PROMs for PCa patients or generic instruments administered to this population were included. The COSMIN risk of bias checklist was adopted to assess the methodological quality and psychometric properties of included PROMs. Psychometric properties of the PROM in each included study were rated against the criteria for good measurement properties based on the COSMIN guideline.

Outcomes: The main outcome was to identify the appropriate PROM that can be adopted and used for assessing sexual functioning in PCa patients in clinical setting.

Results: A total of 10 PROMs were identified across 32 studies, primarily focusing on localized PCa patients after radical prostatectomy. The Expanded Prostate Cancer Index Composite (EPIC-26) was the most frequently evaluated and widely used PROM in clinical practice. EPIC-26 (Spanish, Italian, Chinese versions) and UCLA Prostate Cancer Index (UCLA-PCI) demonstrated better psychometric properties compared to other scales. However, no PROM met all COSMIN standards.

Clinical implications: In a clinical setting, it is crucial to utilize well-validated PROMs with good psychometric properties to effectively identify patients with PCa experiencing sexual difficulties who may require additional support.

Strengths and limitations: We applied strict inclusion criteria related to study design and study population, ensuring the assumption of transitivity and the consistency of the analysis.

Conclusion: Although EPIC-26 is a shortened version with strong psychometric properties, it may still be too lengthy for patients with significant health issues. Furthermore, the included PROMs do not address issues related to partner relationships, or the psychological impact of sexual dysfunction in sufficient detail. Future research should aim to develop and validate new PROMs that fill these gaps. These tools should be both psychometrically robust and practical for routine use, enabling real-time monitoring and improved care delivery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于评估前列腺癌患者性功能的患者报告结果测量(PROMs):心理测量特性的系统回顾。
背景:前列腺癌(PCa)显著影响患者的性功能和生活质量。患者报告的结果测量(PROMs)对于准确评估这些问题至关重要,但缺乏对PCa患者心理测量特性的全面评估。目的:本系统综述旨在全面评价用于评估PCa患者性功能的所有通用和特异性PROMs,并提出PROMs在该患者组中的应用建议。方法:检索截至2024年5月5日的6个电子数据库。研究报告了PCa患者的PROMs的开发和/或验证,或用于该人群的通用器械。采用COSMIN偏倚风险检查表评估纳入的PROMs的方法学质量和心理测量学特性。在每个纳入的研究中,根据基于COSMIN指南的良好测量特性标准对PROM的心理测量特性进行评级。结果:主要结果是确定在临床环境中可用于评估PCa患者性功能的合适的PROM。结果:在32项研究中共发现了10个PROMs,主要集中在根治性前列腺切除术后的局限性PCa患者。前列腺癌扩展指数(EPIC-26)是临床中最常用的诊断方法。EPIC-26(西班牙语、意大利语、中文版本)和UCLA前列腺癌指数(UCLA- pci)比其他量表表现出更好的心理测量特性。然而,没有一个舞会符合COSMIN的所有标准。临床意义:在临床环境中,使用具有良好心理测量特性的经过良好验证的PROMs来有效识别可能需要额外支持的PCa性困难患者是至关重要的。优势与局限性:我们采用了与研究设计和研究人群相关的严格纳入标准,确保了传递性假设和分析的一致性。结论:虽然EPIC-26是一个具有较强心理测量特性的缩短版,但对于有重大健康问题的患者来说,它可能仍然太长。此外,所包括的prom并没有充分详细地解决与伴侣关系有关的问题,或者性功能障碍的心理影响。未来的研究应该致力于开发和验证新的prom来填补这些空白。这些工具在心理测量学上应该是稳健的,并且在日常使用中是实用的,能够实时监测和改善护理提供。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Sexual Medicine
Journal of Sexual Medicine 医学-泌尿学与肾脏学
CiteScore
6.20
自引率
5.70%
发文量
826
审稿时长
2-4 weeks
期刊介绍: The Journal of Sexual Medicine publishes multidisciplinary basic science and clinical research to define and understand the scientific basis of male, female, and couples sexual function and dysfunction. As an official journal of the International Society for Sexual Medicine and the International Society for the Study of Women''s Sexual Health, it provides healthcare professionals in sexual medicine with essential educational content and promotes the exchange of scientific information generated from experimental and clinical research. The Journal of Sexual Medicine includes basic science and clinical research studies in the psychologic and biologic aspects of male, female, and couples sexual function and dysfunction, and highlights new observations and research, results with innovative treatments and all other topics relevant to clinical sexual medicine. The objective of The Journal of Sexual Medicine is to serve as an interdisciplinary forum to integrate the exchange among disciplines concerned with the whole field of human sexuality. The journal accomplishes this objective by publishing original articles, as well as other scientific and educational documents that support the mission of the International Society for Sexual Medicine.
期刊最新文献
2018 American Urological Association Guidelines for evaluation and management of testosterone deficiency: insights into utilization in clinical practice. Association between age at first sexual intercourse and all-cause mortality in adults: two nationwide cohort studies in the USA and UK. S100 calcium-binding protein B ameliorates premature ejaculation in rats via regulation of the BDNF/5-HT pathway. Testosterone use trends among young men in the era of direct-to-consumer healthcare. Exploring sexual arousal synchrony: A pilot study on dyadic sexual arousal covariation in the lab.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1